secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-10-16T20:30:14+00:00
Accession:  0001213900-26-110266
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Envoy Medical holders approve reverse split of 1-for-5 to 1-for-25 by Dec. 31, 2026
--------------------------------------------------------------------------------

- At the Oct. 12, 2026 Special Meeting, stockholders approved amending the charter to let the board effect one or more reverse splits of Class A common stock at ratios from 1-for-5 to 1-for-25.
- The reverse split authority expires on or before December 31, 2026, and any split is at the discretion of the Board of Directors.
- Reverse Stock Split Proposal tallied 44,012,206 votes for, 50,668 against and 1,872 abstained.
- The Adjournment Proposal passed 43,642,799 for, 406,221 against and 15,726 abstained; the adjournment authority was not used.
- CEO Brent T. Lucas signed the report Oct. 16, 2026; Class A common stock trades as COCH and warrants as COCHW on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/0001213900-26-110266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/ea0308812-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-110266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer